241 related articles for article (PubMed ID: 32605113)
1. The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function-A Comprehensive Review.
Kumari S; Adewale R; Klubo-Gwiezdzinska J
Cells; 2020 Jun; 9(7):. PubMed ID: 32605113
[TBL] [Abstract][Full Text] [Related]
2. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
Máximo V; Sobrinho-Simões M
Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
[TBL] [Abstract][Full Text] [Related]
3. Forward Genetic Screens Identify Mechanisms of Resistance to Small-Molecule Lactate Dehydrogenase Inhibitors.
Frank AR; Vandiver F; McFadden DG
ACS Chem Biol; 2024 Feb; 19(2):471-482. PubMed ID: 38270591
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial-Encoded Complex I Impairment Induces a Targetable Dependency on Aerobic Fermentation in Hürthle Cell Carcinoma of the Thyroid.
Frank AR; Li V; Shelton SD; Kim J; Stott GM; Neckers LM; Xie Y; Williams NS; Mishra P; McFadden DG
Cancer Discov; 2023 Aug; 13(8):1884-1903. PubMed ID: 37262072
[TBL] [Abstract][Full Text] [Related]
5. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
Máximo V; Botelho T; Capela J; Soares P; Lima J; Taveira A; Amaro T; Barbosa AP; Preto A; Harach HR; Williams D; Sobrinho-Simões M
Br J Cancer; 2005 May; 92(10):1892-8. PubMed ID: 15841082
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
7. Do Molecular Profiles of Primary
Gomes-Lima CJ; Shobab L; Wu D; Ylli D; Bikas A; McCoy M; Feldman R; Lee W; Rao SN; Jensen K; Vasko V; Castro LC; Jonklaas J; Wartofsky L; Burman KD
Front Endocrinol (Lausanne); 2021; 12():623182. PubMed ID: 33716974
[TBL] [Abstract][Full Text] [Related]
8. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma.
Addie RD; Kostidis S; Corver WE; Oosting J; Aminzadeh-Gohari S; Feichtinger RG; Kofler B; Aydemirli MD; Giera M; Morreau H
Sci Rep; 2020 Jun; 10(1):9578. PubMed ID: 32533088
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial activities of a cell line derived from thyroid Hürthle cell tumors.
Stankov K; Biondi A; D'Aurelio M; Gasparre G; Falasca A; Romeo G; Lenaz G
Thyroid; 2006 Apr; 16(4):325-31. PubMed ID: 16646677
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
Yi HS; Chang JY; Kim KS; Shong M
Korean J Intern Med; 2017 Sep; 32(5):780-789. PubMed ID: 28823142
[TBL] [Abstract][Full Text] [Related]
14. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
Gopal RK; Kübler K; Calvo SE; Polak P; Livitz D; Rosebrock D; Sadow PM; Campbell B; Donovan SE; Amin S; Gigliotti BJ; Grabarek Z; Hess JM; Stewart C; Braunstein LZ; Arndt PF; Mordecai S; Shih AR; Chaves F; Zhan T; Lubitz CC; Kim J; Iafrate AJ; Wirth L; Parangi S; Leshchiner I; Daniels GH; Mootha VK; Dias-Santagata D; Getz G; McFadden DG
Cancer Cell; 2018 Aug; 34(2):242-255.e5. PubMed ID: 30107175
[TBL] [Abstract][Full Text] [Related]
15. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hürthle cell thyroid cancer.
Plotkin M; Hautzel H; Krause BJ; Schmidt D; Larisch R; Mottaghy FM; Boemer AR; Herzog H; Vosberg H; Müller-Gärtner HW
Thyroid; 2002 Feb; 12(2):155-61. PubMed ID: 11916285
[TBL] [Abstract][Full Text] [Related]
16. The biology and the genetics of Hurthle cell tumors of the thyroid.
Máximo V; Lima J; Prazeres H; Soares P; Sobrinho-Simões M
Endocr Relat Cancer; 2012 Aug; 19(4):R131-47. PubMed ID: 22514109
[TBL] [Abstract][Full Text] [Related]
17. Selenoprotein expression in Hürthle cell carcinomas and in the human Hürthle cell carcinoma line XTC.UC1.
Menth M; Schmutzler C; Mentrup B; Hoang-Vu C; Takahashi K; Honjoh T; Köhrle J
Thyroid; 2005 May; 15(5):405-16. PubMed ID: 15929660
[TBL] [Abstract][Full Text] [Related]
18. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Mitochondrial Function in Blood Samples Shows Distinct Patterns in Subjects with Thyroid Carcinoma from Those with Hyperplasia.
Bernal-Tirapo J; Bayo Jiménez MT; Yuste-García P; Cordova I; Peñas A; García-Borda FJ; Quintela C; Prieto I; Sánchez-Ramos C; Ferrero-Herrero E; Monsalve M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047426
[TBL] [Abstract][Full Text] [Related]
20. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ganly I; McFadden DG
Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
